Private company
Sanofi Vaccines US Inc.
Biological product manufacturing
- Federal commitments · since Oct 2024
- $105M
- Contracts ending · 18mFull contract value
- $77.3M
- Top payer
- Office of Assistant Secretary for Preparedness and Response
What's developing
- New: $6M Health and Human Services contract for manufacture and stability studies of thimerosal-free pandemic influenza… (21 Sep 2026).
Ask Intel
Source-backedRecords as of 18 Nov 2026.